Home » Trials » SLCTR/2025/001


Comparative Analysis of Pre- and Postoperative Dexamethasone Administration in Lower Third Molar Surgery: A Randomized Controlled Trial

-

SLCTR Registration Number

SLCTR/2025/001


Date of Registration

21 Jan 2025

The date of last modification

Feb 17, 2025


View original TRDS



Application Summary


Scientific Title of Trial

Comparative Analysis of Pre- and Postoperative Dexamethasone Administration in Lower Third Molar Surgery: A Randomized Controlled Trial


Public Title of Trial

Comparison of Pre-Operative Versus Post-Operative Dexamethasone Administration on Post-Operative Complications in Lower Third Molar Surgery using Saline as a Control: A Randomized Clinical Trial with


Disease or Health Condition(s) Studied

Bony impacted lower third molars.


Scientific Acronym

CADA-LTM


Public Acronym

None


Brief title

Dexamethasone administration in lower third molar surgery.


Universal Trial Number

U1111-1313-2546


Any other number(s) assigned to the trial and issuing authority

ODC-2024-AS-203:Research & Innovation Committee, Oman


Trial Details


What is the research question being addressed?

How does preoperative versus postoperative administration of dexamethasone, compared to saline as a placebo affect postoperative complications in lower third molar surgery?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded : Participants, Healthcare providers


Control

Placebo


Assignment

Other


Purpose

Treatment


Study Phase

Phase 1


Intervention(s) planned

The study will be conducted in a clinical-based setting, specifically within the Department of Oral Surgery at Oman Dental College, located in Muscat, Oman.

Patients planned for lower third molar surgery will be recruited from the outpatient clinic of the Department of Oral Surgery and will be randomised to four groups using the [include random selection method] Intervention will be as follows

Four groups
Group 1: Patients receiving pre-operative normal saline
Group 2: Patients receiving pre-operative dexamethasone submucosal injections in 4mg
Group 3: Patients receiving post-operative saline
Group 4: Patients receiving post-operative dexamethasone submucosal injections in 4mg


Inclusion criteria

Inclusion Criteria: -
* All ages
* Both men and women
* Individuals officially diagnosed with lower bony impacted third molars. Diagonosis is according to winter’s classification (horizontal, vertical, mesioangular, distoangular). OPGs (orthopantomogram) will be taken for all participants. Using this radiograph, the type of impaction will be determined.
* Patients scheduled to undergo surgical extraction of bony impacted lower third molar surgery at the oral Surgery Department in Oman Dental College.

• Patients must possess the ability to self-administer the questionnaire. This includes having the literacy and comprehension skills necessary to understand and respond accurately to the modified validated Arabic version of the Post-operative symptoms following surgical removal of lower wisdom teeth Questionnaire.


Exclusion criteria

Exclusion Criteria:
• Patients who took pre-op antibiotics.
• Individuals with cognitive impairments that impede their ability to understand the consent process or to accurately fill out the questionnaires.
• Patients with None bony impaction that might affect the surgery's outcomes or their ability to participate fully in the study.



Primary outcome(s)

1.

1.Visual analogue scale: a modified validated Arabic version, consisting of 15 questions across 3 sections: pain, swelling and trismus. The score ranges from 0 to 5, with lower scores indicating better outcomes.

[

[post surgery for 5 days on each day]

]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

60. (15 per group)


Countries of recruitment

Oman


Anticipated start date

2025-01-22


Anticipated end date

2025-10-01


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

Private


Regulatory approvals

Ethics, Research & Innovation Committee (ERIC), Oman Dental College, Muscat, Oman



State of Ethics Review Approval


Status

Approved


Date of Approval

2024-09-12


Approval number

ODC-2024-AS-203


Details of Ethics Review Committee

Name: Ethics, Research & Innovation Committee
Institutional Address:Oman Dental College PO Box 835, Mina Al Fahal, Postal Code 116 Sultanate of Oman
Telephone:0096824665555
Email: research@staff.odc.edu.om

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Amur Alsenaidi
Assistant Professor
Oman Dental College PO Box 835, Mina Al Fahal, Postal Code 116 Sultanate of Oman
96894388846
96897647585
none
aalsenaidi@staff.odc.edu.om
none

Contact Person for Public Queries

Amur Alsenaidi
Assistant Professor
Oman Dental College PO Box 835, Mina Al Fahal, Postal Code 116 Sultanate of Oman
96894388846
96897647585
none
aalsenaidi@staff.odc.edu.om
none


Primary study sponsor/organization

Oman Dental College

Oman Dental College PO Box 835, Mina Al Fahal, Postal Code 116 Sultanate of Oman
0014384672704
None

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

No


IPD sharing plan description

Not Applicable


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results